Wei Mu

6PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 30, 2025
CD5 ablation enhances persistence and antitumor potency of engineered T cells by mitigating exhaustion and promoting cytotoxicity.

Jia Wu, Jiali Cheng, Li Zhu

|May 07, 2025
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacy.

Jiahao Liu, Xiaofei Jiao, Wei Mu

|Apr 08, 2025
Engineering CD5-targeting CAR-NK cells from peripheral blood for the treatment of CD5-positive hematological malignancies.

Haolong Lin, Lingfeng Zhang, Tong Ge

|Jan 21, 2025
Unlocking the Potential of CAR-NK Cell Therapy: Overcoming Barriers and Challenges in the Treatment of Myeloid Malignancies.

Anqi Zhang, Xingcheng Yang, Yicheng Zhang

Pageof 1

Frequent Collaborators

3 joint publications

Haolong Lin

2 joint publications

Yuhao Zeng

2 joint publications

Xiaojian Zhu

1 joint publications

Anqi Zhang